Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries.
Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries.
复制标题
DOI:
10.1161/strokeaha.113.003165
复制
发表时间:
2013-12
期刊:
影响因子:
8.3
通讯作者:
Goldstein LB
中科院分区:
文献类型:
--
作者:
Lichtman JH;Leifheit-Limson EC;Jones SB;Wang Y;Goldstein LB
The Centers for Medicare and Medicaid Services (CMS) proposes to use 30-day hospital readmissions after ischemic stroke as part of the Hospital Inpatient Quality Reporting Program for payment determination beginning in 2016. The proportion of post-stroke readmissions that is potentially preventable is unknown. Thirty-day readmissions for all Medicare fee-for-service beneficiaries aged ≥65 years discharged alive with a primary diagnosis of ischemic stroke (ICD-9-CM 433, 434, 436) between 12/2005-11/2006 were analyzed. Preventable readmissions were identified based on 14 Prevention Quality Indicators developed for use with administrative data by the US Agency for Healthcare Research and Quality (AHRQ). National, hospital-level, and regional preventable readmission rates were estimated. A random-effects logistic regression model was also used to determine patient-level factors associated with preventable readmissions. Among 307,887 ischemic stroke discharges, 44,379 (14.4%) were readmitted within 30 days; 5,322 (1.7% of all discharges) were the result of a preventable cause (e.g., pneumonia) and 39,057 (12.7%) were for other reasons (e.g., cancer). In multivariate analysis, older age and cardiovascular-related comorbid conditions were strong predictors of preventable readmissions. Preventable readmission rates were highest in the Southeast, Mid-Atlantic, and US territories and lowest in the Mountain and Pacific regions. Based on the AHRQ Prevention Quality Indicators, we found that a small proportion of readmissions after ischemic stroke were classified as preventable. Although other causes of readmissions not reflected in the AHRQ measures could also be avoidable, hospital-level programs intended to reduce all-cause readmissions and reduce costs should target these high-risk patients.